Zurich Cantonal Bank’s Immunic IMUX Stock Holding History

Zurich Cantonal Bank’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-303	Closed	-$10K	–	2874
2022 Q3	$10K	Hold	303	–	–	﹤0.01%	2859
2022 Q2	$11K	Hold	303	–	–	﹤0.01%	2848
2022 Q1	$34K	Buy	+303	New	+$35.1K	﹤0.01%	2595

Other funds holding IMUX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Zurich Cantonal Bank's IMUX Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of Immunic (IMUX) in Q4 2022, closing a stake of 303 shares — an estimated $10K sold.

Zurich Cantonal Bank first reported a position in IMUX in Q1 2022 and held it in 3 quarters. The position peaked at $34K in Q1 2022. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

Zurich Cantonal Bank reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
Zurich Cantonal Bank sold 303 Immunic shares in Q4 2022, an estimated $10K.
Zurich Cantonal Bank first reported a position in Immunic in Q1 2022 and held it in 3 quarters.
Zurich Cantonal Bank's Immunic position peaked at $34K in Q1 2022.
58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.